hotspot -WSS

hotspot

author：Wikipedia 2025-09-29 01:46:02 - browse：59699

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： A deep dive into Applied Therapeutics’ data, and questions on Cassava

focus

WSS

Change Healthcare payments predicted restored March 15

Pandemic and All Hazards Preparedness Act needs lean update

White House announces new plan to address the growing threat of xylazine in overdose crisis

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Home health providers sue Medicare over payment cuts

Sen. Paul opposes bill to ban Chinese biotechs

focus

hotspot

Wikipedia

Peter Hotez and the public health issue of online harassment

Change Healthcare payments predicted restored March 15

Heart attack and stroke risk calculators need revising

Sen. Paul opposes bill to ban Chinese biotechs

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Virginia high school admissions case could be legal follow

Amylyx ALS drug fails large clinical trial

In Memoriam: Notable people who died in 2023

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

hotspot

Home health providers sue Medicare over payment cuts

Change Healthcare cyberattack prompts Medicare loan program

What it’s like to watch children die of measles

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Amylyx ALS drug failure raises questions and concerns

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

entertainment

focus

focus

knowledge